Participated · Equity · Jun 2026

Founded in 2016, Innovafeed develops technology to rear and transform the Black Soldier Fly (Hermetia illucens) at industrial scale to produce protein and oil ingredients for animal and plant nutrition. Its proprietary, sensor-driven and partially robotic production process and wet transformation method aim to optimise breeding conditions and product digestibility. The company says its Nesle production unit is fully operational and has produced over 15,000 tons of protein and oil in three years while increasing volumes tenfold and cutting production costs by seven. Innovafeed plans to prioritise commercial deployment of its Hilucia™ product ranges—particularly in functional segments of aquaculture and pet food—while redirecting investment toward industrial equipment, applications development, and operational excellence. As part of this new phase the company is reorganising activities around Nesle, integrating R&D from Gouzeaucourt and planning a workforce reduction tied to that integration. Innovafeed reports strong commercial traction with revenues doubling annually and emphasizes the environmental benefits of its circular industrial model.

Participated · Equity · Dec 2025

Nous anti-gaspi focuses on sourcing and reselling products that are downgraded, surplus, or otherwise at risk of being discarded, allowing consumers to purchase them at discounted prices while reducing waste. The company positions itself as a specialist in destocking these goods, offering a branded product range under the Nous anti-gaspi label. It is now initiating a strategic shift, accompanied by a change in governance. As part of this transition, it has secured a €7 million capital increase. The fresh funds come largely from its long-standing backers, Creadev (the investment arm of the Mulliez family) and Eutopia. This new financing provides additional resources to support the company’s evolving strategy and operational needs.

Participated · Series B · Nov 2025

Founded in 2014, Damae Medical’s mission is to let dermatologists observe skin at the cellular scale directly during consultations. Its core product, deepLive™, delivers instant, non-invasive cellular imaging supported by a real-time, CE-certified AI engine. Backed by more than a decade of R&D and over 250 scientific publications, deepLive™ is already installed in 120+ sites across 15+ countries, spanning hospitals and private practices. The system is used from initial diagnosis to intra-operative surgical guidance, helping thousands of patients avoid unnecessary biopsies, repeat surgeries and long waiting times. With the technology now commercially launched, the company plans to broaden access beyond early pioneer centers and make digital biopsy a routine part of dermatological care. The newly secured Series B funding strengthens its financial position and fuels this expansion. Damae Medical continues to focus on accelerating adoption, improving accuracy and reducing invasiveness in skin-cancer management.

Participated · Equity · Sep 2025

Founded in 2019, NxtFood produces plant-based chicken, beef, and pork alternatives made from locally grown wheat and pea proteins. Its 20-plus SKUs are distributed in all major French food retailers and more than 10,000 foodservice outlets, making it one of the country’s fastest-growing alt-meat startups. Revenue rose from €1 million in 2022 to €9.2 million in 2023, and the company expects to reach €17.4 million in 2024. NxtFood operates a high-moisture-extrusion facility in Vitry-en-Artois and plans to triple its footprint to 12,000 m². The fresh capital will also fund additional R&D and accelerate sales and co-manufacturing partnerships across Europe. Management targets profitability within 12–18 months and emphasizes short ingredient lists, balanced nutrition, and clean labels to meet consumer demand.

Participated · Series B · Oct 2024

The Jackfruit Company, founded in 2011 by Annie Ryu and based in Boulder, CO, produces 100% vegetarian dishes under its consumer brand Jack & Annie’s. The company's products all feature jackfruit as the primary ingredient. It works with over 1,000 farming families to supply jackfruit to more than 6,000 retailers across the United States. The company intends to use the funds to expand operations and support its development efforts. On 14/10/2024 it raised $5M in a Series B extension backed by InvestEco, Creadev, and Grosvenor Food & AgTech.